Wordt geladen...
IAP antagonists enhance cytokine production from mouse and human iNKT cells
Inhibitor of apoptosis protein (IAP) antagonists are in clinical trials for a variety of cancers, and mouse models show synergism between IAP antagonists and anti–PD-1 immunotherapy. Although IAP antagonists affect the intrinsic signaling of tumor cells, their most pronounced effects are on immune c...
Bewaard in:
| Gepubliceerd in: | Cancer Immunol Res |
|---|---|
| Hoofdauteurs: | , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2017
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5754232/ https://ncbi.nlm.nih.gov/pubmed/29187357 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/2326-6066.CIR-17-0490 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|